You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DAS28

Showing 1 - 25 of 2,324
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rheumatoid Arthritis Trial (Treatment target DAS28CRP-LDA, Treatment target SDAI-remission)

Not yet recruiting
  • Rheumatoid Arthritis
  • Treatment target DAS28CRP-LDA
  • Treatment target SDAI-remission
  • (no location specified)
Sep 13, 2023

Rheumatoid Arthritis, Vitamin D , Disease Activity, DAS28ESR Trial in Bangkok (Vitamin D 2, Placebo)

Recruiting
  • Rheumatoid Arthritis, Vitamin D , Disease Activity, DAS28ESR
  • Vitamin D 2
  • Placebo
  • Bangkok, Thailand
    Rajavithi hospital
May 31, 2021

Response Assessment in Newly Diagnosed RA Patients at 3rd Month Was Evaluated by DAS28 and ACR in Relation to JAK Expression

Completed
  • Response Assessment in Newly Diagnosed RA Patients at 3rd Month Was Evaluated by DAS28 and ACR in Relation to JAK Expression
  • JAK expression
  • Mansoura, Egypt
    Mansoura University Hospital
Dec 9, 2020

Rheumatoid Arthritis Trial in Assiut (Doxycycline Tablets)

Completed
  • Rheumatoid Arthritis
  • Doxycycline Tablets
  • Assiut, Egypt
    Assiut University
May 14, 2020

Rheumatoid Arthritis Trial (Baricitinib 4 MG, Placebo)

Not yet recruiting
  • Rheumatoid Arthritis
  • Baricitinib 4 MG
  • Placebo
  • (no location specified)
Jul 27, 2023

Rheumatoid Arthritis Trial (GS-5718, Placebo to match GS-5718, Tofacitinib 5 mg)

Withdrawn
  • Rheumatoid Arthritis
  • (no location specified)
May 11, 2022

Rheumatoid Arthritis Trial (SBD121, Placebo)

Not yet recruiting
  • Rheumatoid Arthritis
  • SBD121
  • Placebo
  • (no location specified)
Aug 16, 2023

Anti-Carbamylated Antibody Status in Rheumatoid Arthritis

Completed
Has Results
  • RheumatoId Arthritis
    • Monterrey, Nuevo León, Mexico
      Servicio de Reumatología, Departamento de Medicina Interna, Facu
    Dec 3, 2021

    Rheumatic Arthritis Trial in Germany (Tofacitinib, Etanercept)

    Recruiting
    • Rheumatic Arthritis
    • Berlin, Germany
    • +5 more
    Mar 1, 2022

    Rheumatoid Arthritis Trial (SAR441566, Placebo)

    Not yet recruiting
    • Rheumatoid Arthritis
    • (no location specified)
    Oct 4, 2023

    Rheumatoid Arthritis Trial in Strasbourg (Spironolactone, Placebo)

    Recruiting
    • Rheumatoid Arthritis
    • Strasbourg, Alsace, France
      University Hospital, Strasbourg, France
    Aug 17, 2022

    Rheumatoid Arthritis Trial in Belgium (Rituximab)

    Not yet recruiting
    • Rheumatoid Arthritis
    • Merksem, Antwerpen, Belgium
    • +6 more
    Aug 17, 2023

    Rheumatoid Arthritis Trial in Beijing (TLL-018, Tofacitinib)

    Not yet recruiting
    • Rheumatoid Arthritis
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Aug 25, 2023

    Rheumatoid Arthritis (RA) Trial in Korea, Republic of (tacrolimus, methotrexate, adalimumab)

    Completed
    • Rheumatoid Arthritis (RA)
    • Daegu, Korea, Republic of
    • +9 more
    Aug 26, 2021

    Periodontitis, Rheumatoid Arthritis Trial in Kuala Lumpur (Nonsurgical periodontal therapy)

    Recruiting
    • Periodontitis
    • Rheumatoid Arthritis
    • Nonsurgical periodontal therapy
    • Kuala Lumpur, Federal Territory, Malaysia
      Universiti Malaya
    May 18, 2023

    Rheumatoid Arthritis Trial in Sakarya (exercise, gene expressions of miRNA)

    Completed
    • Rheumatoid Arthritis
    • exercise
    • gene expressions of miRNA
    • Sakarya, Turkey
      Sakarya Training and Research Hospital
    Jun 13, 2023

    Arthritis, Rheumatoid Trial in Upland, Plantation, Mesquite (Placebo, Nipocalimab, Certolizumab)

    Recruiting
    • Arthritis, Rheumatoid
    • Placebo
    • +2 more
    • Upland, California
    • +2 more
    Sep 1, 2023

    Rheumatoid Arthritis Trial in China (Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection)

    Completed
    • Rheumatoid Arthritis
    • Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection
    • Beijing, Beijing, China
    • +14 more
    Jul 21, 2023

    STudying Ageing in Rheumatic Diseases (STAR)

    Not yet recruiting
    • Rheumatoid Arthritis
    • Rheumatoid arthritis
    • (no location specified)
    Jul 14, 2022

    Rheumatoid Arthritis Trial in Beijing (bortezomib)

    Not yet recruiting
    • Rheumatoid Arthritis
    • Beijing, China
      Peking Union Medical College Hospital
    Apr 6, 2023

    Arthritis, Rheumatoid Trial in Jinan (Iguratimod, Methotrexate, Adalimumab Injection)

    Recruiting
    • Arthritis, Rheumatoid
    • Jinan, Shandong, China
      Qilu Hospital
    Nov 28, 2022

    Rheumatoid Arthritis Trial in Beijing (LNK01001 Dose A, LNK01001 Dose B, )

    Completed
    • Rheumatoid Arthritis
    • LNK01001 Dose A
    • +2 more
    • Beijing, China
      Peking Union Medical College Hospital
    Oct 24, 2023

    Rheumatoid Arthritis Trial (Raloxifene HCl, Placebo Oral Tablet)

    Completed
    • Rheumatoid Arthritis
    • Raloxifene hydrochloride
    • Placebo Oral Tablet
    • (no location specified)
    Dec 1, 2021

    Arthritis, Psoriatic, Arthritis, Rheumatoid, Deformity, Hand Trial in Porto (Digital Rehabilitation, Conventional

    Not yet recruiting
    • Arthritis, Psoriatic
    • +5 more
    • Digital Rehabilitation
    • Conventional Rehabilitation
    • Porto, Vila Nova De Gaia, Portugal
      Centro Hospitalar de Vila Nova de Gaia-Espinho, E.P.E.
    Oct 4, 2023

    Rheumatoid Arthritis Trial in Worldwide (Sarilumab, Adalimumab, Placebo (for sarilumab))

    Completed
    Has Results
    • Rheumatoid Arthritis
    • Covina, California
    • +85 more
    Mar 15, 2022